PatternsRadar
Sign in

VIVIMEDLABVivimed Labs Limited

NSEIRPBand 2%
5.02INR-0.09 (-1.76%)Close · 20 Nov 2026
17 Jul 2026Last results
—Sector
—Industry
₹42 CrMarket cap
—P/E (TTM)
100.0%Delivery

Filings & corporate actions

2 results filed
CSV
Next results · Q1 FY27
Due — expected by 14 Aug 2026
Estimate: filed 43–45 days after quarter end, last 4 times
Dividend
₹0.40 per share · last 19 Sept 2018
2026
  • 17 JulresultsResults · Q4 FY26 · consolidated and standalone+0.6%NSE
  • 17 AprshareholdingShareholding · 31 Mar 2026+4.9%NSE
  • 13 MarresultsResults · Q3 FY26 · consolidated-3.9%NSE
  • 9 JanshareholdingShareholding · 31 Dec 2025-5.0%NSE

Reaction to results · all yearsrose on day 0 in 1 of 74 CSV

QuarterFiledDay 0+5D+20DRel vol
Q4 FY2617 Jul 2026+0.6%+0.6%-1.5%0.7×
Q3 FY2613 Mar 2026-3.9%-12.9%+12.6%0.6×
Q2 FY2614 Nov 2025————
Q1 FY2614 Aug 2025————
Q4 FY2531 May 2025————
Q3 FY2515 Feb 2025————
Q2 FY2517 Jan 2025————
Q1 FY2516 Jan 2025————
Q4 FY2415 Nov 2024————
Q3 FY2415 Feb 2024————
Q2 FY2415 Nov 2023————
Q1 FY2414 Aug 2023————
Q4 FY2331 May 2023————
Q3 FY2313 Feb 2023————
Q2 FY2315 Nov 2022————
Q1 FY2312 Aug 2022————
Q4 FY226 Jun 2022————
Q3 FY2214 Feb 2022————
Q2 FY2213 Nov 2021————
Q1 FY2213 Aug 2021————
Q4 FY2129 Jun 2021————
Q3 FY2113 Feb 2021————
Q2 FY2114 Nov 2020————
Q1 FY2129 Aug 2020————
Q4 FY2025 Jul 2020————
Q3 FY2015 Feb 2020————
Q2 FY2015 Nov 2019————
Q1 FY209 Aug 2019————
Q4 FY191 Jun 2019————
Q3 FY191 Mar 2019————
Q2 FY1922 Nov 2018————
Q1 FY1931 Aug 2018————
Q4 FY1825 Jun 2018————
Q3 FY1823 Feb 2018————
Q2 FY1822 Nov 2017————
Q1 FY174 Sept 2017————
Q4 FY174 Sept 2017————
Q1 FY184 Sept 2017————
Q3 FY1717 Feb 2017————
Q2 FY1714 Nov 2016————
Q4 FY161 Jun 2016————
Q3 FY1619 Feb 2016————
Q2 FY1613 Nov 2015————
Q4 FY153 Jun 2015————
Q3 FY1519 Feb 2015————
Q2 FY1526 Nov 2014————
Q1 FY1520 Aug 2014————
Q4 FY146 Jun 2014————
Q3 FY1419 Feb 2014————
Q2 FY1422 Nov 2013————
Q1 FY1417 Aug 2013————
Q4 FY1324 Jun 2013————
Q3 FY1322 Feb 2013————
Q2 FY1315 Nov 2012————
Q1 FY135 Sept 2012————
Q4 FY121 Jun 2012————
Q3 FY1214 Feb 2012————
Q2 FY1216 Nov 2011————
Q1 FY1217 Aug 2011————
Q4 FY1131 May 2011————
Q3 FY1131 Jan 2011————
Q2 FY1125 Oct 2010————
Q1 FY1116 Aug 2010————
Q4 FY1031 May 2010————
Q3 FY1029 Jan 2010————
Q2 FY1028 Oct 2009————
Q1 FY101 Aug 2009————
Q3 FY0921 Jan 2009————
Q2 FY094 Nov 2008————
Q1 FY0931 Jul 2008————
Q3 FY0824 Jan 2008————
Q2 FY085 Nov 2007————
Q1 FY0827 Jul 2007————
Q4 FY0730 Apr 2007————
Average-1.7%-6.2%+5.6%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q4 FY26

Revenue YoY-53.2%
Profit YoY—
Interest cost YoY+41.9%
Revenue QoQ-24.9%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue-31.5%-27.9%-26.3%-39.3%-36.4%—
Profit——————

Key data

Open5.10
Day range5.02 – 5.10
52-week range—
From 52w high—
RSI (14)27.0
ATR (14)0.17
Volume63.1K
Avg volume (20D)21.2K
Rel volume2.98×
Volatility (1Y)53.1%
Turnover₹3.2L
Traded value (NSE)₹3.2L
VWAP5.03
SMA 50 / 2005.83 / 6.25
Price band2%

Delivery percentage

Latest · 20 Nov 2026100.0%
20-day avg100.0%
1-year avg93.6%
Percentile (own history)100th
Range28.2–100.0%
Sessions229

Over the last 20 sessions VIVIMEDLAB settled 100.0% of its traded quantity, which is unusually high for an NSE equity. Its one-year average is 93.6%, so recent sessions are running 6.4 points higher than usual.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders47.5K · -3.5% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy283 days ago

Performance returns

1D1W1M3M6M1Y
Price-1.76%-3.46%-19.16%-15.63%-23.36%—

Valuation

Market cap₹42 Cr
Market cap (NSE)₹42 Cr
Free-float cap₹38 Cr
P/E (TTM)—
P/E (NSE)—
EPS (TTM)-21.15
P/B—
Net margin (TTM)-250.6%
Other income / PBT—
ROE—
Debt / equity—
Shares outstanding—
Listed—

Ownership

Promoter7.57%
Promoter Δ QoQ-0.20 pp
Public92.43%
FII1.64%
DII0.00%
Pledged15.18%

Quarterly results · consolidated

Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue (₹ Cr)21.420.616.012.0
YoY chg-27.2%-16.8%-56.2%-53.2%
Net profit (₹ Cr)(5.5)(7.3)(16.6)(146.0)
YoY chg————
Net margin-25.7%-35.4%-103.5%-1217.0%
EPS-0.64-0.85-0.85-17.22

Shareholding over time

By quarter

31 Mar 2026 · promoter 7.57% · public 92.43%
30 Jun 2021: promoter 28.57%30 Sept 2021: promoter 28.57%31 Dec 2021: promoter 28.57%31 Mar 2022: promoter 21.98%30 Jun 2022: promoter 20.96%30 Sept 2022: promoter 20.96%31 Dec 2022: promoter 20.96%31 Mar 2023: promoter 20.94%30 Jun 2023: promoter 20.94%30 Sept 2023: promoter 20.94%31 Dec 2023: promoter 20.94%31 Mar 2024: promoter 20.94%30 Jun 2024: promoter 20.94%30 Sept 2024: promoter 20.94%31 Dec 2024: promoter 20.94%31 Mar 2025: promoter 20.94%30 Jun 2025: promoter 7.77%30 Sept 2025: promoter 7.77%31 Dec 2025: promoter 7.77%31 Mar 2026: promoter 7.57%
2021-062026-03
  • Promoter
  • Public and others
Promoter
7.57%
Public
92.43%
Promoter change
-0.20 pp
Filed
17 Apr 2026
FII
1.64%
DII
0.00%
Promoter pledged
15.18%

Who the public is

Mutual funds
0.00%

0.00 pp QoQ

Insurance
0.00%

0.00 pp QoQ

FPI
1.64%

0.00 pp QoQ

Retail ≤ ₹2L
57.49%

+0.15 pp QoQ

HNI > ₹2L
11.26%

+3.54 pp QoQ

NRI
4.40%

-0.15 pp QoQ

Bodies corporate
6.43%

-3.35 pp QoQ

Shareholders
47,492

-3.5% QoQ

Major holders

As of 31 Mar 2026
HolderTypeHolding
KITARA PIIN 1102Corporate9.37%
VARALWAR SANDEEPPromoter · Individual2.81%
WILLIAM F HARVEYIndividual1.65%
SAMEER MAHENDRA SAMPATIndividual1.64%
SUBHASH VARALWARPromoter · Individual1.63%
AMICORP CAPITAL (MAURITIUS) LIMITEDFPI1.47%
ASHISH BHARATKUMAR SHAHIndividual1.42%
MONARCH NETWORTH FINSERVE PRIVATE LIMITEDCorporate1.24%
JAGAT FOODS PRIVATE LIMITEDCorporate1.12%
SHEETAL VARALWARPromoter · Individual0.83%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 21 Sept 2012 CSV
Financial yearPaymentsDeclaredAdjusted
FY2018-191₹0.40₹0.40
FY2017-181₹0.40₹0.40
FY2014-151₹3.00₹0.60
FY2013-141₹3.00₹0.60
FY2012-131₹3.00₹0.60
Ex-dateRecord dateDeclaredAdjusted
19 Sept 2018—₹0.40₹0.40
21 Sept 2017—₹0.40₹0.40
24 Sept 2014—₹3.00₹0.60
24 Sept 2013—₹3.00₹0.60
21 Sept 2012—₹3.00₹0.60

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Price-band hits

Loading…

Sessions the stock closed at the limit of its daily price band, from NSE's end-of-day list. A stock pinned at the band could not trade past it that day.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
6.7 years ago
Disclosures on record
33
10 open-market of the newest 33
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
17 Mar 2020SANDEEP VARALWARPromoterBuy1.37L₹2.7L2.0017.39L → 18.76L2.26%+0.17 pp7(2)told 17 Mar 2020
12 Mar 2020SANDEEP VARALWARPromoterBuy1.77L₹3.5L2.0015.62L → 17.39L2.10%+0.21 pp7(2)told 11 Mar 2020
10 Mar 2020SANDEEP VARALWARPromoterBuy92.3K₹1.8L2.0014.70L → 15.62L1.88%+0.11 pp7(2)told 10 Mar 2020
22 Mar 2018BBR Projects Private LimitedPromoterBuy1.00L——1.31Cr → 1.32Cr15.94%+0.12 pp7(2)told 22 Mar 2018
22 Mar 2018BBR Projects Private LimitedPromoterBuy1.00L——1.30Cr → 1.31Cr15.82%+0.12 pp7(2)told 21 Mar 2018
17 Mar 2018BBR Projects Private LimitedPromoterBuy1.35L₹2.7L2.001.28Cr → 1.30Cr15.71%+0.16 pp7(2)told 16 Mar 2018
14 Mar 2018BBR Projects Private LimitedPromoterBuy2.00L₹4.0L2.001.26Cr → 1.28Cr15.54%+0.24 pp7(2)told 14 Mar 2018
14 Mar 2018BBR Projects Private LimitedPromoterBuy1.45L₹2.9L2.001.25Cr → 1.26Cr15.30%+0.18 pp7(2)told 14 Mar 2018
20 Jun 2016VIJAYKUMAR VARALWARPromoterSell32.0K——2.11L → 1.79L0.22%-0.04 pp7(2)told 20 Jun 2016
17 May 2016VIJAYKUMAR VARALWARPromoterSell38.5K——2.50L → 2.11L0.26%-0.05 pp7(2)told 14 May 2016

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 10 Feb 2026

CSV
12 of 387 deals
By year
DateDealClientQuantityPriceValue
10 Feb 2026Sell · bulkKRONE FINSTOCK PRIVATE LIMITED5.81L7.41₹43.1L
10 Feb 2026Buy · bulkKRONE FINSTOCK PRIVATE LIMITED6.0K7.68₹46,157
20 Jan 2026Buy · bulkKAMAL JEET GUPTA4.30L8.17₹35.1L
20 Jan 2026Sell · bulkKAMAL JEET GUPTA1.30L7.82₹10.2L
6 Jan 2026Buy · bulkNEO APEX VENTURE LLP10.49L12.25₹1.3Cr
6 Jan 2026Buy · bulkMERU INVESTMENTS4.50L12.25₹55.1L
6 Jan 2026Sell · bulkNEO APEX VENTURE LLP2.99L12.25₹36.6L
3 Apr 2023Buy · bulkA AND S TRADELINK7.13L6.42₹45.7L
21 Jun 2022Sell · bulkLUHARUKA MEDIA & INFRA LTD5.52L7.66₹42.3L
29 Mar 2022Sell · bulkKRONE FINSTOCK PRIVATE LIMITED4.31L15.15₹65.3L
25 Jan 2022Sell · bulkSBICAP TRUSTEE COMPANY LIMITED4.29L20.14₹86.4L
21 Jan 2022Sell · bulkSBICAP TRUSTEE COMPANY LIMITED6.00L20.93₹1.3Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026
  • BZ/SZ series · since 22 Oct 2026 — Moved to the BZ/SZ series for not complying with listing rules.
  • Insolvency (IRP) · stage 1 · since 9 Oct 2026 — The company is in an insolvency resolution process.
  • Under 100 traders in 30 days · since 21 May 2026 — Fewer than 100 distinct investors traded it in the last 30 days.
  • Zero EPS (4 quarters) · since 17 Dec 2025 — Zero EPS over the last four quarters.

Price band: 2% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25ARQ1 FY26Q2 FY26Q3 FY26Q4 FY26A
Revenue from operations35.433.641.538.629.424.836.525.621.420.616.012.0
Other income0.12.20.07.60.10.00.14.20.40.20.05.7
Total income35.535.841.546.229.424.836.629.821.820.816.017.7
Total expenses51.056.158.139.637.629.942.634.927.328.132.5163.6
└ Finance costs10.711.913.2(33.3)0.30.40.51.70.61.71.00.9
└ Depreciation4.74.74.75.84.04.16.65.55.04.94.611.5
Profit before tax(15.6)(20.3)(16.6)6.7(8.2)(5.1)(6.0)(5.0)(5.5)(7.3)(16.6)(145.9)
Tax expense0.00.0(0.6)1.40.00.00.00.10.00.00.00.1
Net profit(15.6)(20.3)(16.0)5.3(8.2)(5.1)(6.0)(5.1)(5.5)(7.3)(16.6)(146.0)
EPS1.88-2.45-1.240.64-0.99-0.60-0.72-0.67-0.66-0.88-0.88-17.74
Net margin-44.06%-60.34%-38.71%13.63%-27.88%-20.75%-16.37%-20.06%-25.68%-35.43%-103.53%-1216.96%
PBT margin-44.06%-60.34%-40.04%17.23%-27.88%-20.75%-16.37%-19.61%-25.68%-35.43%-103.53%-1215.82%
Tax rate———20.91%————————

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 17 Jul 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26
Total assets1,247.8988.31,210.0950.9943.3920.8924.0753.5
Current assets492.7332.3474.3342.6339.0327.6340.6168.0
└ Cash & equivalents2.03.82.32.01.60.21.00.1
└ Other bank balances0.00.00.00.00.00.50.01.3
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables85.276.850.082.888.374.189.345.3
└ Inventories238.479.854.864.160.658.852.712.7
Total equity320.139.4176.8(5.5)(25.8)(35.2)(48.0)(210.6)
└ Attributable to owners320.139.4176.8(5.5)(25.8)(35.2)(48.0)(210.6)
└ Non-controlling interest0.00.0—0.0——0.0—
└ Share capital16.616.616.616.616.616.616.616.6
Borrowings366.2378.6319.7376.9376.5846.6384.0397.3
└ Current304.3316.2256.7313.4313.0312.7320.7325.8
└ Non-current62.062.363.063.663.5533.863.471.5
Trade payables43.869.4(10.4)44.147.239.446.253.2
Current liabilities394.2424.3325.2410.3422.9408.2434.6448.1
Total liabilities927.8948.91,033.2956.4969.1956.0972.0964.0
Net debt364.3374.8317.4374.9374.9845.8383.0396.0
Debt / equity1.149.601.81—————
Current ratio1.250.781.460.830.800.800.780.37

Cash flow, year to date

 H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26
Operating cash flow9.913.8175.1(24.0)3.7(10.8)(18.4)7.7
└ Capex0.0(1.0)(95.1)0.0(4.1)(4.5)0.00.0
Free cash flow9.912.879.9(24.0)(0.5)(15.3)(18.4)7.7
Investing cash flow(4.2)(1.0)(95.1)28.3(4.1)4.511.3(0.9)
Financing cash flow(10.9)(16.2)(81.4)(6.0)0.05.05.5(6.1)
└ Dividends paid0.00.00.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash(5.2)(3.4)(1.5)(1.7)(0.5)(1.3)(1.7)0.6

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

VIVIMEDLAB at a glance

  • VIVIMEDLAB closed at ₹5.02 on 20 Nov 2026, -1.76% on the day.
  • Delivery was 100.0% of traded quantity on 20 Nov 2026, the 100th percentile of its own 229 sessions with a reading (20-session average 100.0%, 1-year average 93.6%).
  • Market capitalisation is ₹42 crore, with no positive trailing earnings for a P/E (trailing EPS ₹-21.15).
  • Q4 FY26 results (consolidated, filed 17 Jul 2026): revenue ₹12 crore (-53.2% year on year), net profit ₹-146 crore; the price moved +0.6% on the first session after.
  • Promoters held 7.57% at 31 Mar 2026, down 0.20 percentage points on the previous filing, with 15.18% of promoter shares pledged.
  • Q1 FY27 results are due; going by past filing dates they were expected by 14 Aug 2026.

About

Macro sector—
Basic industry—
ISININE526G01021
SeriesBZ
Listed—
NSE market cap · 17 Nov 2026—
Free-float market cap (NSE)—
Shares outstanding (NSE)—
History from18 Dec 2025
Sessions229

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.